Julia Wood
Psychiatry · Knoxville, TNNPI 1245435825
Payments from drug & device makers
Across 400 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$739
- Neurocrine Biosciences, Inc.$631
- AbbVie$615
- Lundbeck LLC$565
- Otsuka America Pharmaceutical, Inc.$487
- Takeda Pharmaceuticals U.S.A., Inc.$451
- plus $3K from 24 others
What the payments were for
- Food & beverage$6,32797%
- Education$1723%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 44 | $739 |
| Neurocrine Biosciences, Inc. | 35 | $631 |
| AbbVie(2 entities) | 40 | $615 |
| Lundbeck LLC | 46 | $565 |
| Otsuka America Pharmaceutical, Inc. | 34 | $487 |
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $451 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $391 |
| Alkermes, Inc. | 18 | $334 |
| Axsome Therapeutics, Inc. | 17 | $323 |
| Sunovion Pharmaceuticals Inc. | 19 | $255 |
| Neos Therapeutics, LP | 9 | $162 |
| Vanda Pharmaceuticals Inc. | 10 | $159 |
| Ironshore Pharmaceuticals Inc. | 8 | $154 |
| Avanir Pharmaceuticals, Inc. | 10 | $148 |
| Tris Pharma Inc | 8 | $146 |
| Bausch Health US, LLC | 9 | $139 |
| Corium, LLC | 6 | $119 |
| Idorsia Pharmaceuticals US Inc | 6 | $111 |
| Supernus Pharmaceuticals, Inc. | 5 | $103 |
| Almatica Pharma LLC | 6 | $90 |
| Acadia Pharmaceuticals Inc | 4 | $67 |
| Johnson & Johnson | 4 | $66 |
| E.r. Squibb & Sons, L.L.C. | 3 | $51 |
| Sage Therapeutics, LLC | 2 | $49 |
| Arbor Pharmaceuticals, Inc. | 3 | $42 |
| Eisai Inc. | 2 | $30 |
| Shire North American Group Inc | 2 | $25 |
| Merck | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
How this compares
$6,498 in reported general payments places this provider in the 85th percentile of 503 psychiatry providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 12 | $102,756 |
| VraylarCariprazine Hcl | 31 | $42,215 |
| TrintellixVortioxetine Hydrobromide | 41 | $35,136 |
| BelsomraSuvorexant | 14 | $6,988 |
| FetzimaLevomilnacipran Hcl | 13 | $6,098 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 164 | $4,567 |
| Vilazodone Hcl | 16 | $4,135 |
| Aripiprazole | 21 | $3,825 |
| Bupropion XlBupropion Hcl | 118 | $3,565 |
| Duloxetine Hcl | 86 | $3,247 |
| Clozapine | 45 | $2,075 |
| Clomipramine Hcl | 21 | $1,993 |
| Dextroamphetamine Sulfate | 22 | $1,944 |
| Quetiapine Fumarate | 99 | $1,880 |
| Lamotrigine | 124 | $1,817 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $631 | $102,75612 claims |
| AbbVieVraylar, Fetzima | $615 | $48,31344 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $451 | $35,13641 claims |
| MerckBelsomra | $17 | $6,98814 claims |
| Almatica Pharma LLCSertraline Hcl | $90 | $62475 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 503 psychiatry providers in Tennessee.
Other psychiatry in Knoxville
- Karthi NamasivayamKnoxville$225K
- Lane CookKnoxville$53K
- Richard GibsonKnoxville$32K
- Kelley WalkerKnoxville$17K
- Sharon BurnsideKnoxville$16K
- James KennedyKnoxville$15K
- Bryan WestKnoxville$15K
- Kris HouserKnoxville$14K
- Charles MayKnoxville$9K
- Rakesh AminNashville$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.